Monday, 18 July 2022

High blood thickness ups death risk; few problems with flu-COVID shots together

High blood thickness ups death risk; few problems with flu-COVID shots together

The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review.

Shanghai enforces new COVID testing, some areas in China extend lockdowns

Several large Chinese cities including Shanghai are rolling out new mass testing or extending lockdowns on millions of residents to counter new clusters of COVID-19 infections, with some measures being criticised on the internet.

Fauci plans to retire by end of U.S. President Biden's term

Dr. Anthony Fauci, the chief medical adviser to the White House, confirmed he will retire by the end of President Joe Biden's first term, but it could come much earlier than that, the infectious disease expert told Reuters in an interview on Monday.

Quebec avoids new COVID mandates ahead of fall election as hospitals fill up

A new wave of COVID-19 cases and rising hospitalizations ahead of an October election are creating fresh headaches for Quebec's government, which says it has no plans to reintroduce mask mandates in the Canadian province despite calls by some doctors to do so.

Uber settles U.S. lawsuit over disabled riders, vows to waive fees

Uber will pay more than $2 million and waive wait time fees for disabled passengers to settle U.S. allegations that it had violated the Americans with Disabilities Act, the Department of Justice said.

EU regulator reviews Pfizer-BioNTech COVID shot in children as young as 6 months

The European Medicines Agency on Monday started reviewing a low-dose version of BioNTech and Pfizer's COVID-19 vaccine for use in children between the age of six months and four years.

The health risks of extreme heat

Europe is sweltering under a record-breaking heatwave, with a number of governments issuing health emergency alerts.

EU secures 54,000 more doses of Bavarian Nordic's monkeypox vaccine

The European Commission said on Monday it has secured about 54,000 additional doses of the monkeypox vaccine developed by biotech firm Bavarian Nordic as concern mounts over the disease amid a spike in cases.

Years of neglect leaves sexual health clinics ill-prepared for monkeypox

Sexual health clinics on the frontline of the monkeypox response are already financially stretched, leaving the United States and UK ill-equipped to tackle the first major global health test since the COVID-19 pandemic.

GSK's consumer arm Haleon debuts with lacklustre valuation

British drugmaker GSKspun off its consumer health business on Monday in the biggest listing in Europe for more than a decade, but the unit's market value of 30.5 billion pounds fell well short of the price rival Unilever offered to pay earlier this year.

Related Videos

Suicide prevention hotline launches nationwide

Pig heart transplants successful in brain-dead patients

Monkeypox could move into high-risk groups: WHO